• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HYGINETT HUNGARIAN AMERICAN CO WHISPERPADSINFINITYINFINITYBASEVERWINGREGNORNONDO10CT; PAD, MENSTRUAL, UNSCENTED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HYGINETT HUNGARIAN AMERICAN CO WHISPERPADSINFINITYINFINITYBASEVERWINGREGNORNONDO10CT; PAD, MENSTRUAL, UNSCENTED Back to Search Results
Lot Number NOT AVAILABLE
Device Problem Insufficient Information (3190)
Patient Problems Cyst(s) (1800); Hypersensitivity/Allergic reaction (1907); Swelling (2091)
Event Date 12/01/2019
Event Type  Injury  
Manufacturer Narrative
There is insufficient information to perform a product investigation.
 
Event Description
Bartholin cyst [bartholin's cyst], allergic reaction [hypersensitivity], vulva rashes [vulvovaginal rash], pimples vulva [acne], redness vulva [vulvovaginal erythema], vulva swelling [vulvovaginal swelling].A spontaneous report was received via e-mail on 22-dec-2019 from a store stating a consumer, a female of unknown age, used whisper pads infinity base version wing regular-normal non deodorant 10ct on an unspecified date, and experienced an allergic reaction.The outcome was unknown.No further information was provided.23-dec-2019 follow-up with consumer via phone: the consumer reported she began using the whisper pads on the first day of her period which was on (b)(6) 2019.It was the first time she had used this product.She changed the sanitary napkin once every 1 to 2 hours.After using the product for 4 days, her vulva developed rashes, pimples, redness, and swelling.The pimples were as big as her thumb.Her period lasted 5 to 7 days, and product use was discontinued (b)(6) 2019.She sought medical attention on (b)(6) 1 bottle per day.Each day's medical consultation took 1 and a half hours.She reported her condition had not recovered.The outcomes of all adverse events were not recovered/not resolved.The consumer reported she had not experience similar symptoms in the past, and she had always used sanitary napkins from anion.Concomitant product(s): none reported.No further information was provided.06-jan-2020 follow-up with consumer via phone: the consumer reported she was hospitalized on (b)(6) 2019 and discharged around (b)(6) 2019.She had a bartholin's cyst and suturing was required.The sutures were removed, and she was at the hospital every day now.The outcome of bartholin's cyst was unknown.The case outcome remained not recovered/not resolved.No further information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WHISPERPADSINFINITYINFINITYBASEVERWINGREGNORNONDO10CT
Type of Device
PAD, MENSTRUAL, UNSCENTED
Manufacturer (Section D)
HYGINETT HUNGARIAN AMERICAN CO
hatar u.3
csomor,
HU 
Manufacturer (Section G)
HYGINETT HUNGARIAN AMERICAN CO
hatar u.3
csomor,
HU  
Manufacturer Contact
regulatory feminine care
winton hill business center
b6280 center hill avenue
cincinnati, OH 45224
MDR Report Key9671226
MDR Text Key190123160
Report Number1219109-2020-00001
Device Sequence Number1
Product Code HHD
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign
Reporter Occupation Other
Type of Report Initial
Report Date 12/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Lot NumberNOT AVAILABLE
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/06/2020
Initial Date FDA Received02/05/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-